ETX Share Price Performance
UK£0
0.00 (0.00%)
Price UK£0
Share Pricen/a
e-therapeutics plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ETX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
e-therapeutics plc Key Details
Last Reported Earnings
Jul 31, 2023
Next Reporting Earnings
n/a
- -0.017
- 100.00%
- -2,957.65%
- 0%
About ETX
- Founded
- 2001
- Employees
- 34
- CEO
- WebsiteView website
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
